Targeted Chinese Medicine Delivery by A New Family of Biodegradable Pseudo-Protein Nanoparticles for Treating Triple-Negative Breast Cancer: In Vitro and In Vivo Study

por Kwan, Hiu Yee, Xu, Qinghua, Gong, Ruihong, Bian, Zhaoxiang, Chu, Chih-Chang
Publicado 2021

Halofuginone and artemisinin synergistically arrest cancer cells at the G1/G0 phase by upregulating p21(Cip1) and p27(Kip1)

por Chen, Guoqing, Gong, Ruihong, Shi, Xianli, Yang, Dajian, Zhang, Ge, Lu, Aiping, Yue, Jianbo, Bian, Zhaoxiang
Publicado 2016

Dihydroartemisinin is potential therapeutics for treating late-stage CRC by targeting the elevated c-Myc level

por Hu, Xianjing, Fatima, Sarwat, Chen, Minting, Huang, Tao, Chen, Yuen Wa, Gong, Ruihong, Wong, Hoi Leong Xavier, Yu, Rongmin, Song, Liyan, Kwan, Hiu Yee, Bian, Zhaoxiang
Publicado 2021